Complex Regional Pain Syndrome (CRPS) Market Overview, Opportunities, and Development 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Complex Regional Pain Syndrome (CRPS) Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Disease Type (CRPS I, CRPS II, CRPS-NOS); Therapy Type (Drugs, Spinal Cord Stimulation, Surgical Sympathectomy); Route of Administration (Oral Therapy, Intravenous Therapy); Distribution Channel (Hospital Pharmacy, Reatil Pharmacy, Online Pharmacy); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00040821
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Mar 2025

AI overview of Complex Regional Pain Syndrome (CRPS) Market


The Complex Regional Pain Syndrome (CRPS) Market is poised for significant growth, with a projected market size reaching US$ XX million by 2031, reflecting a CAGR of 4.9% from 2025 to 2031. This market, which encompasses various segments such as CRPS I, CRPS II, and CRPS-NOS, is driven by the increasing incidence of trauma and advancements in pain management techniques. Notably, the rising awareness and improved diagnosis of CRPS are contributing to its expansion. Future trends indicate a shift towards personalized and targeted therapies, alongside the integration of innovative solutions like virtual reality for pain relief. As the market evolves, opportunities in rehabilitation, biologics, and telemedicine are expected to further enhance the Complex Regional Pain Syndrome (CRPS) Market Share.


The Complex Regional Pain Syndrome (CRPS) Market is expected to register a CAGR of 4.9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented By Disease Type (CRPS I, CRPS II, and CRPS-NOS), Therapy Type (Drugs, Spinal Cord Stimulation, Surgical Sympathectomy, and Others), Route of Administration (Oral Therapy, Intravenous Therapy), Distribution Channel (Hospital Pharmacy, Reatil Pharmacy, Online Pharmacy). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Complex Regional Pain Syndrome (CRPS) Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Complex Regional Pain Syndrome (CRPS) Market Segmentation

Disease Type

  • CRPS I
  • CRPS II
  • CRPS-NOS

Therapy Type

  • Drugs
  • Spinal Cord Stimulation
  • Surgical Sympathectomy

Route of Administration

  • Oral Therapy
  • Intravenous Therapy

Distribution Channel

  • Hospital Pharmacy
  • Reatil Pharmacy
  • Online Pharmacy

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Complex Regional Pain Syndrome (CRPS) Market: Strategic Insights

complex-regional-pain-syndrome-crps-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Complex Regional Pain Syndrome (CRPS) Market Growth Drivers

  • Increasing Incidence of Trauma and Surgery: The rising incidence of trauma and surgeries, particularly fractures, is a key driver for the complex regional pain syndrome (CRPS) market. CRPS often develops after injury or surgical procedures, leading to persistent pain and disability. As the number of trauma cases and surgeries increases globally, the demand for effective treatments and management options for CRPS continues to grow.
  • Advancements in Pain Management Techniques: Recent advancements in pain management, including nerve block techniques, spinal cord stimulation, and emerging biologic therapies, are driving the CRPS market. These innovations provide more effective and targeted treatment options for CRPS patients, improving quality of life and reducing chronic pain. As the understanding of CRPS mechanisms improves, more advanced therapies are being developed to address its complexities.
  • Rising Awareness and Improved Diagnosis: Increased awareness and improved diagnostic capabilities are fueling the CRPS market. Previously underdiagnosed, CRPS is now more frequently identified due to better education among healthcare professionals and patients. Enhanced diagnostic tools and criteria for CRPS are enabling earlier detection and treatment, contributing to the growing market for therapies aimed at managing this debilitating condition.

Complex Regional Pain Syndrome (CRPS) Market Future Trends

  • Personalized and Targeted Therapies: A growing trend in the CRPS market is the shift towards personalized and targeted therapies. These therapies are designed based on the individual’s genetic profile, specific pain mechanisms, and response to treatments. By tailoring CRPS treatment to each patient's unique condition, the market is moving toward more effective, long-term solutions that improve patient outcomes and reduce pain.
  • Non-Opioid Pain Management Solutions: There is a rising trend toward non-opioid pain management solutions for CRPS. With growing concerns over opioid use and addiction, alternative therapies such as nerve blocks, physical therapy, and neuromodulation techniques are gaining popularity. Non-opioid pain management options are expected to dominate the CRPS treatment market as they offer safer, sustainable relief for patients.
  • Integration of Virtual Reality for Pain Relief: The integration of virtual reality (VR) as a therapeutic tool for CRPS is an emerging trend. VR-based treatments are being developed to help patients manage pain and improve motor functions by distracting the brain and providing immersive environments. This innovative approach shows potential for reducing CRPS-related pain and enhancing rehabilitation, making it a growing trend in pain management.

Complex Regional Pain Syndrome (CRPS) Market Opportunities

  • Growth in Rehabilitation and Physical Therapy Solutions: There is a significant opportunity for growth in CRPS rehabilitation and physical therapy solutions. As physical therapy is essential in managing CRPS symptoms, there is rising demand for specialized rehabilitation programs that focus on restoring function and alleviating pain. Companies providing these targeted therapies can expand their presence in the growing market for CRPS management.
  • Expanding Biologics and Stem Cell Research: The increasing focus on biologic treatments and stem cell research presents a promising opportunity for the CRPS market. Emerging therapies targeting the underlying inflammation and nerve regeneration mechanisms in CRPS are showing potential. As research in regenerative medicine progresses, stem cell-based therapies and biologics could revolutionize the treatment landscape for CRPS patients, offering new, effective solutions.
  • Telemedicine and Remote Monitoring Solutions: The rise of telemedicine and remote monitoring in healthcare presents an opportunity for the CRPS market. Telehealth services, including virtual consultations and digital pain management programs, can enhance patient access to specialized CRPS care, especially in underserved areas. By providing continuous monitoring and personalized treatment plans remotely, telemedicine could significantly improve patient outcomes in CRPS management.

Complex Regional Pain Syndrome (CRPS) Market Regional Insights

The regional trends and factors influencing the Complex Regional Pain Syndrome (CRPS) Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Complex Regional Pain Syndrome (CRPS) Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

complex-regional-pain-syndrome-crps-market-global-geography
  • Get the Regional Specific Data for Complex Regional Pain Syndrome (CRPS) Market

Complex Regional Pain Syndrome (CRPS) Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 4.9%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Disease Type
  • CRPS I
  • CRPS II
  • CRPS-NOS
By Therapy Type
  • Drugs
  • Spinal Cord Stimulation
  • Surgical Sympathectomy
By Route of Administration
  • Oral Therapy
  • Intravenous Therapy
By Distribution Channel
  • Hospital Pharmacy
  • Reatil Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • AbbVie
  • Averitas Pharma
  • Boston Scientific
  • Collegium Pharmaceutical
  • Eli Lilly and Company
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • Nevro
  • Pfizer

  • Complex Regional Pain Syndrome (CRPS) Market Players Density: Understanding Its Impact on Business Dynamics

    The Complex Regional Pain Syndrome (CRPS) Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Complex Regional Pain Syndrome (CRPS) Market are:

    1. Abbott Laboratories
    2. AbbVie
    3. Averitas Pharma
    4. Boston Scientific
    5. Collegium Pharmaceutical
    6. Eli Lilly and Company

    Disclaimer: The companies listed above are not ranked in any particular order.


    complex-regional-pain-syndrome-crps-market-cagr

    • Get the Complex Regional Pain Syndrome (CRPS) Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Complex Regional Pain Syndrome (CRPS) Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Complex Regional Pain Syndrome (CRPS) Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What is the expected CAGR of the complex regional pain syndrome market?
    The complex regional pain syndrome market is estimated to witness a CAGR of 4.9% from 2025 to 2031
    2
    What are the driving factors impacting the complex regional pain syndrome market?
    The major factors driving the complex regional pain syndrome market are:

    1.Increasing Incidence of Trauma and Surgery

    2. Advancements in Pain Management Techniques

    3. Rising Awareness and Improved Diagnosis
    3
    Which region dominated the complex regional pain syndrome market in 2024?
    North America region dominated the complex regional pain syndrome market in 2024
    4
    Which region higesh CAGR the complex regional pain syndrome market in 2024?
    Asia Pacific region dominated the complex regional pain syndrome market in 2024
    5
    Which segment accounts for highest revenue in disease type segment of the complex regional pain syndrome market in 2024?
    The CRPS I segment accounts for highest revenue in disease type sgement in 2024
    6
    Which are some of the major players operating in the market?
    Abbott Laboratories, AbbVie, Averitas Pharma, Boston Scientific, Collegium Pharmaceutical, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Medtronic, Nevro, Pfizer are some of the major market players operating in the market
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    • Abbott Laboratories

    • AbbVie

    • Averitas Pharma

    • Boston Scientific

    • Collegium Pharmaceutical

    • Eli Lilly and Company

    • Mallinckrodt Pharmaceuticals

    • Medtronic

    • Nevro

    • Pfizer

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo